Archive | Innovation Challenge RSS feed for this section

Announcing RESI Asia Innovation Challenge Finalists

31 Oct

By Karen Deyo, Senior Investor Research Analyst, LSN

We are excited to announce the finalists in the Innovation Challenge at both RESI Shanghai, taking place on Tuesday, Nov. 12th and RESI Taipei, taking place on Thursday, Nov. 14th. These companies will present posters in the Exhibit Hall, where RESI attendees can see their innovative technologies and ‘invest’ their ‘RESI cash’ tokens to vote for their favorite companies. The three companies with the most ‘invested’ by the end of the day will win prizes.

In addition to presenting posters, for the first time, each company will also get an opportunity to pitch to a panel of investors and industry experts, who will ask questions and provide feedback. Below are the pitching schedules for the selected companies – make sure to stop by and watch these amazing companies pitch!

RESI Shanghai Innovation & Pitch Challenge

RESI Taipei Innovation & Pitch Challenge

VIVA Biotech, Shanghai, China based CRO will be the Innovation Challenge Gold Sponsor for RESI

24 Oct

By Candice He, Global Investment Strategist, LSN

After supporting the RESI Conference Series with delegates and speakers for many years, VIVA Biotech has become a Gold Sponsor of RESI Shanghai and RESI San Francisco.  At RESI, you will be able to meet with VIVA’s delegation of elite portfolio companies, and with top expert speakers representing VIVA at RESI’s panels and pitch sessions. You will also have the opportunity to meet with VIVA during RESI’s cocktail party, where VIVA will present the awards for the RESI Innovation Challenge!  Finally, RESI Shanghai attendees will also have the opportunity to take a tour of VIVA Biotech’s incubator.  We hope you will join us and our sponsors and partners at RESI Shanghai.

About VIVA Biotech

Viva Biotech’s mission is to become a cradle for innovative biotechnology companies around the world. Viva Biotech has developed a scalable business model combing the conventional cash-for-service (CFS) model and its unique equity-for-service (EFS) model. Under the CFS model, the Group provides structure-based drug discovery services to its biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development, covering the full spectrum of the customers’ needs for early stage drug discovery, including target protein expression and structure research, hit screening, lead optimization and drug candidate determination. Viva Biotech also provides drug discovery and incubation services to biotechnology start-up companies with high potential under its EFS model. As of June 30, 2019, Viva Biotech had provided drug discovery services to 388 biotechnology and pharmaceutical customers worldwide, worked on over 1,000 independent drug targets, delivered over 11,000 independent protein structures, and incubated a total of 37 early stage R&D projects.

Supporting RESI Conferences for years, VIVA Biotech will be the Innovation Challenge Gold Sponsor for RESI Shanghai on Nov. 12th and RESI San Francisco on Nov. 14th

FOUR Chances to Present at RESI Asia!

10 Oct

By Gregory Mannix, Vice President International Business Development, LSN

That’s right – RESI Asia will, for the first time, allow participants to present their companies four times over the course of two days. By applying to the Innovation Challenge for RESI Asia, companies will get the chance to present a poster in the exhibition hall AND pitch to a panel of investors at both the Shanghai RESI conference on November 12th and the Taipei RESI conference on November 14th. That is an incredible opportunity to get visibility for your company and meet with many investors and strategics from China, Asia-Pacific and beyond.

We know from experience that companies that compete as finalists in the Innovation Challenge at a RESI conference get more visibility and more one-on-one meetings with investors. The opportunity this November, with two conferences back-to-back in two hot life science hubs in Asia, is UNPRECEDENTED.

As always, participating in the RESI Innovation Challenge carries no additional cost for companies. You’ve got nothing to lose, and everything to gain!

%d bloggers like this: